A study investigating if inhibiting the Notch pathway prevents osteosarcoma growth demonstrated that a γ-secretase inhibitor attenuated the cyclin D1, cyclin E1, E2, and SKP2 expression [36]. Here, SKP2 is linked to osteosarcoma.